Identification of

Hepatocellular carcinoma (HCC) TP53 mutation immunotype net benefit overall survival (OS)

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 2 5 2020
Statut: ppublish

Résumé

Stratification of tumors is necessary to achieve better clinical outcomes. Hepatocellular carcinoma (HCC) is commonly associated with mutation of the The mutation annotation format (MAF) document, mRNA expression data, and clinical data of HCC patients were downloaded from the publicly available The Cancer Genome Atlas (TCGA) data portal. Data from 332 HCC patients were analyzed in this study. Infiltrating immune cells were evaluated by the well-known CIBERSORT method. Additional mutation data of HCC patients were downloaded from the Catalogue of Somatic Mutations in Cancer (COSMIC) database. The Two distinct immunotypes of HCC, in terms of prognosis, phenotype, and function, were identified and the traditional understanding of intratumoralCD8

Sections du résumé

BACKGROUND BACKGROUND
Stratification of tumors is necessary to achieve better clinical outcomes. Hepatocellular carcinoma (HCC) is commonly associated with mutation of the
METHODS METHODS
The mutation annotation format (MAF) document, mRNA expression data, and clinical data of HCC patients were downloaded from the publicly available The Cancer Genome Atlas (TCGA) data portal. Data from 332 HCC patients were analyzed in this study. Infiltrating immune cells were evaluated by the well-known CIBERSORT method. Additional mutation data of HCC patients were downloaded from the Catalogue of Somatic Mutations in Cancer (COSMIC) database.
RESULTS RESULTS
The
CONCLUSIONS CONCLUSIONS
Two distinct immunotypes of HCC, in terms of prognosis, phenotype, and function, were identified and the traditional understanding of intratumoralCD8

Identifiants

pubmed: 32355765
doi: 10.21037/atm.2020.02.98
pii: atm-08-06-321
pmc: PMC7186599
doi:

Types de publication

Journal Article

Langues

eng

Pagination

321

Informations de copyright

2020 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

Bioinformatics. 2016 Oct 1;32(19):3012-4
pubmed: 27288499
Cell. 2018 Jun 14;173(7):1770-1782.e14
pubmed: 29906450
Clin Cancer Res. 2018 Jul 1;24(13):3069-3078
pubmed: 29514839
Genome Biol. 2003;4(5):P3
pubmed: 12734009
Ann Hematol. 2018 Feb;97(2):229-237
pubmed: 29128997
J Clin Transl Hepatol. 2015 Sep 28;3(3):182-8
pubmed: 26623264
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
Clin Cancer Res. 2017 Jun 15;23(12):3012-3024
pubmed: 28039262
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):333-342
pubmed: 28400627
Nat Med. 2015 May;21(5):449-56
pubmed: 25894828
Nat Commun. 2018 Feb 22;9(1):771
pubmed: 29472616
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Nat Commun. 2018 Nov 2;9(1):4586
pubmed: 30389912
Nucleic Acids Res. 2018 Jun 1;46(10):e60
pubmed: 29562348
Nucleic Acids Res. 2009 Jan;37(Database issue):D623-8
pubmed: 18940869
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
Hum Mutat. 2014 Jun;35(6):672-88
pubmed: 24665023
J Clin Oncol. 2017 Mar;35(7):734-742
pubmed: 28068175
Nat Med. 2019 Jan;25(1):89-94
pubmed: 30510250
Gastroenterology. 2017 Sep;153(3):812-826
pubmed: 28624577
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008
pubmed: 20182602
Nat Med. 2018 Jul;24(7):978-985
pubmed: 29942094
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Cancer Discov. 2018 Dec;8(12):1548-1565
pubmed: 30322867
J Clin Invest. 2019 Mar 1;129(3):1109-1114
pubmed: 30714987
Nucleic Acids Res. 2013 Jan;41(Database issue):D793-800
pubmed: 23143270
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
PLoS One. 2011;6(5):e20297
pubmed: 21655258
Cell. 2017 Jun 15;169(7):1342-1356.e16
pubmed: 28622514
Bioinformatics. 2015 Sep 1;31(17):2912-4
pubmed: 25964631
Nat Rev Cancer. 2016 Apr;16(4):251-65
pubmed: 27009395
Clin Cancer Res. 2015 Apr 15;21(8):1951-61
pubmed: 25248380
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Cancer. 2019 Feb 1;125(3):483
pubmed: 30500071
Clin Cancer Res. 2013 Oct 1;19(19):5300-9
pubmed: 24089443

Auteurs

Muqi Shi (M)

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, and Medical School of Nantong University, Nantong 226001, China.

Yan Wang (Y)

Department of Emergency, Affiliated Hospital of Nantong University, Nantong 226001, China.

Weidong Tang (W)

Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.

Xiaohong Cui (X)

Department of General Surgery, Shanghai Electric Power Hospital, Shanghai 200050, China.

Han Wu (H)

Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.

Yijie Tang (Y)

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, and Medical School of Nantong University, Nantong 226001, China.

Peng Wang (P)

Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.

Wei Wu (W)

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, and Medical School of Nantong University, Nantong 226001, China.

Haijian Zhang (H)

Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, and Medical School of Nantong University, Nantong 226001, China.

Classifications MeSH